ACUTE AND LATE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN SUPPRESSION AND HYPOFRACTIONATED RADIOTHERAPY (HYPORT) TO THE PROSTATE AND PELVIC NODES

被引：0
|
作者：
Faria, Sergio [1 ]
Petrucelli, Mariana [2 ]
Cury, Fabio [1 ]
Duclos, Marie [1 ]
Souhami, Luis [1 ]
机构：
[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[2] Radiat Oncol, Rio De Janeiro, Brazil
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
53
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy
    V. Macias
    R. Gonzalez Celador
    C. Marti-Macia
    C. Cigarral
    L. A. Perez-Romasanta
    Clinical and Translational Oncology, 2013, 15 : 643 - 651
  • [22] Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy
    Macias, V.
    Gonzalez Celador, R.
    Marti-Macia, C.
    Cigarral, C.
    Perez-Romasanta, L. A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (08): : 643 - 651
  • [23] ACUTE TOXICITY IN PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY
    Bellavita, Rita
    Raymondi, Carlo
    Matrone, Fabio
    Massetti, Michela
    Lupattelli, Marco
    Arcidiacono, Fabio
    Mearini, Luigi
    Zucchetti, Claudio
    Palumbo, Isabella
    Aristei, Cynthia
    ANTICANCER RESEARCH, 2011, 31 (05) : 1912 - 1912
  • [24] Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
    Wang, Michael
    Pearcey, Robert
    Pervez, Nadeem
    Yee, Don
    Mihai, Alina
    Patel, Samir
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [25] Acute toxicity of hypofractionated IMRT with simultaneous integrated boost in high-risk prostate cancer patients
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    Souhami, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S689 - S689
  • [26] TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    McCammon, Robert
    Rusthoven, Kyle E.
    Kavanagh, Brian
    Newell, Sherri
    Newman, Francis
    Raben, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 413 - 420
  • [27] Pelvic proton radiotherapy for high-risk prostate cancer
    Chera, B. S.
    Vargas, C.
    Flampouri, S.
    Morris, C. G.
    Yeung, D.
    Olivier, K.
    Duvvuri, S.
    Li, Z.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S326 - S326
  • [28] Postoperative Pelvic Hypofractionated Accelerated Radiotherapy with Cytoprotection (HypoARC) for High-risk or Recurrent Prostate Cancer
    Koukourakis, Michael I.
    Papadopoulou, Aikaterini
    Abatzoglou, Ioannis
    Panteliadou, Marianthi
    Sismanidou, Kyriaki
    Touloupidis, Stavros
    ANTICANCER RESEARCH, 2012, 32 (10) : 4561 - 4568
  • [29] Late toxicity for prostate cancer patients treated with hypofractionated helical tomotherapy
    Cekani, Elona
    Luis Lopez-Guerra, Jose
    Barrientos, Rodrigo
    Tavera, Patricia
    Manuel Praena-Fernandez, Juan
    del Campo, Eleonor Rivin
    Azinovic, Ignacio
    Matute, Raul
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2019, 24 (03) : 298 - 305
  • [30] Salvage hypofractionated radiotherapy for prostate cancer: acute toxicity
    Saldi, S.
    Bellavita, R.
    Palumbo, I.
    Mariucci, C.
    Arena, E.
    Lupattelli, M.
    Podlesko, A.
    Russo, S.
    Dottorini, R.
    Bini, V.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S725 - S725
12345